Four new atypical antidepressants (trazodone, mianserin, nomifensine, caroxazone): results of controlled trials.
D000928:Antidepressive Agents / Q000627:therapeutic use*; D044482:Benzeneacetamides; D002986:Clinical Trials as Topic; D003866:Depressive Disorder / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008297:Male; D008803:Mianserin / Q000627:therapeutic use; D008875:Middle Aged; D009627:Nomifensine / Q000627:therapeutic use; D010078:Oxazines / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D014196:Trazodone / Q000627:therapeutic use
D000928:Antidepressive Agents; D044482:Benzeneacetamides; D010078:Oxazines; D009627:Nomifensine; D008803:Mianserin; C006919:caroxazone; D007099:Imipramine; D014196:Trazodone